Compare AOSL & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AOSL | INMD |
|---|---|---|
| Founded | 2000 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 940.9M | 861.7M |
| IPO Year | 2007 | 2018 |
| Metric | AOSL | INMD |
|---|---|---|
| Price | $19.66 | $13.25 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 6 |
| Target Price | ★ $23.67 | $16.75 |
| AVG Volume (30 Days) | 293.9K | ★ 951.8K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $342,291,000.00 | N/A |
| Revenue This Year | N/A | $1.70 |
| Revenue Next Year | $6.41 | $3.99 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.90 | $13.16 |
| 52 Week High | $33.00 | $19.78 |
| Indicator | AOSL | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 36.79 | 34.62 |
| Support Level | $17.02 | N/A |
| Resistance Level | $23.02 | $14.80 |
| Average True Range (ATR) | 0.94 | 0.32 |
| MACD | -0.25 | -0.12 |
| Stochastic Oscillator | 11.14 | 1.93 |
Alpha & Omega Semiconductor Ltd designs, develops and supplies a portfolio of power semiconductors targeting various applications, including personal computers, flat-panel TVs, LED lighting, smartphones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. It generates revenue mainly from the sale of power semiconductors, consisting of power discretes and power ICs with a presence in Hong Kong, China, South Korea, the United States and other countries. It operates in one operating segment: the design, development and supply of power semiconductor products for computing, consumer electronics, communication and industrial applications.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.